<DOC>
	<DOCNO>NCT01440660</DOCNO>
	<brief_summary>To characterise phenotype Non Proliferative Diabetic Retinopathy ( NPDR ) progression use multimodal testing/imaging procedure .</brief_summary>
	<brief_title>Phenotypes Nonproliferative Diabetic Retinopathy DM 2 Patients Identified OCT , CFP , RLA mfERG ( DIAMARKER )</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>1 . Age 18 yearsold . 2 . Diabetes mellitus type 2 accord 1985 WHO criteria . 3 . Nonproliferative diabetic retinopathy ( ETDRS level &lt; = 35 ) 4 . Signs NPDR progression base exist clinical information : 1 . Retinal thickness ( RT ) increase ( increase RT normal range measure OCT , consider macular thickness normative data ) central subfield , inner ring and/or outer ring ( leak phenotype ) ; OR 2 . Neovascular disease activity show microaneurysms ( MA ) turnover ( MA formation rate &gt; = 2 , i.e . number new MA per year ) compute CFP use RetmarkerDR software ( ischemic phenotype ) . 5 . Informed consent . 1 . Cataract eye disease may interfere fundus examination 2 . Any eye surgery treatment within period 6months . 3 . Pregnant nursing ( lactate ) woman . 4 . Patients chronic severe kidney disease ( glomerular filtration rate , GFR &lt; 30 mL/min/1.73m2 ) . 5 . Patients acute kidney injury . 6 . Patients know allergic hypersensitivity reaction gadolinium , versetamide inert ingredient . 7 . Patients around time liver transplantation.. 8 . Patients implant contain metal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>